Reason for request
Reassessment of the actual benefit (AB) and improvement in actual benefit (IAB).
Clinical Benefit
| Substantial |
The actual benefit of VERSATIS is substantial. |
Clinical Added Value
| minor |
The new clinical data available indicates that VERSATIS provides a minor improvement in actual benefit (level IV) in the management of post-herpetic pain in adults. |
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
Xwt0PnThnz61KaH6
